Disease ID | Disease name | Source of annotation with TNF | OMIM link | Number of associated genes | genes |
---|---|---|---|---|---|
611162 | MALARIA, SUSCEPTIBILITY TO | OMIM | link to OMIM | 16 | FCGR2A, TIRAP, ICAM1, ACKR1, G6PD, GYPC, TNF, SLC4A1, NOS2, HBB, CISH, GYPB, FCGR2B, CR1, CD36, GYPA |
157300 | MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1 | OMIM | link to OMIM | 3 | EDNRA, ESR1, TNF |
600807 | ASTHMA, SUSCEPTIBILITY TO | ClinVar, OMIM | link to OMIM | 13 | HLA-G, SCGB1A1, PLA2G7, PHF11, MUC7, TNF, HNMT, IL13, SPINK5, SCGB3A2, CCL11, ALOX5, ADRB2 |
Download the gene annotation in CSV format
KEGG pathway | KEGG ID | KEGG IC |
---|---|---|
Pertussis | hsa05133 | 6.46 |
Legionellosis | hsa05134 | 6.88 |
Natural killer cell mediated cytotoxicity | hsa04650 | 5.53 |
Asthma | hsa05310 | 7.34 |
Allograft rejection | hsa05330 | 6.91 |
Graft-versus-host disease | hsa05332 | 6.84 |
Osteoclast differentiation | hsa04380 | 5.64 |
Hypertrophic cardiomyopathy (HCM) | hsa05410 | 6.21 |
Type I diabetes mellitus | hsa04940 | 6.79 |
NF-kappa B signaling pathway | hsa04064 | 6.21 |
Dilated cardiomyopathy | hsa05414 | 6.08 |
Cytokine-cytokine receptor interaction | hsa04060 | 4.67 |
Adipocytokine signaling pathway | hsa04920 | 6.6 |
African trypanosomiasis | hsa05143 | 7.68 |
Antigen processing and presentation | hsa04612 | 6.04 |
Chagas disease (American trypanosomiasis) | hsa05142 | 5.99 |
Systemic lupus erythematosus | hsa05322 | 5.95 |
Leishmaniasis | hsa05140 | 6.32 |
Amoebiasis | hsa05146 | 5.82 |
Non-alcoholic fatty liver disease (NAFLD) | hsa04932 | 5.51 |
Malaria | hsa05144 | 7.15 |
Toxoplasmosis | hsa05145 | 5.71 |
Influenza A | hsa05164 | 5.21 |
Herpes simplex infection | hsa05168 | 5.08 |
HTLV-I infection | hsa05166 | 4.59 |
Hepatitis C | hsa05160 | 5.68 |
Hepatitis B | hsa05161 | 5.52 |
TGF-beta signaling pathway | hsa04350 | 6.41 |
Apoptosis | hsa04210 | 6.23 |
Proteoglycans in cancer | hsa05205 | 5.02 |
Rheumatoid arthritis | hsa05323 | 6.05 |
Inflammatory bowel disease (IBD) | hsa05321 | 6.43 |
Toll-like receptor signaling pathway | hsa04620 | 6.0 |
NOD-like receptor signaling pathway | hsa04621 | 6.88 |
RIG-I-like receptor signaling pathway | hsa04622 | 6.62 |
T cell receptor signaling pathway | hsa04660 | 6.01 |
Fc epsilon RI signaling pathway | hsa04664 | 6.6 |
Hematopoietic cell lineage | hsa04640 | 6.18 |
MAPK signaling pathway | hsa04010 | 4.63 |
TNF signaling pathway | hsa04668 | 5.96 |
Type II diabetes mellitus | hsa04930 | 7.12 |
mTOR signaling pathway | hsa04150 | 6.72 |
Tuberculosis | hsa05152 | 5.17 |
Amyotrophic lateral sclerosis (ALS) | hsa05014 | 7.01 |
Alzheimer's disease | hsa05010 | 5.34 |
REACTOME pathway | REACTOME ID | REACTOME IC |
---|---|---|
TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 6.4 |
TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 9.28 |
Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 6.7 |
Immune System | R-HSA-168256 | 2.37 |
Cytokine Signaling in Immune system | R-HSA-1280215 | 3.74 |
Signal Transduction | R-HSA-162582 | 1.78 |
Death Receptor Signalling | R-HSA-73887 | 8.52 |
TNF signaling | R-HSA-75893 | 9.08 |
Developmental Biology | R-HSA-1266738 | 3.48 |
GO term | GO ID | GO IC |
---|---|---|
cytokine receptor binding | GO:0005126 | 4.14 |
transcription regulatory region DNA binding | GO:0044212 | 3.03 |
enzyme binding | GO:0019899 | 2.27 |
tumor necrosis factor receptor superfamily binding | GO:0032813 | 5.89 |
nucleic acid binding | GO:0003676 | 1.44 |
protein binding | GO:0005515 | 0.46 |
organic cyclic compound binding | GO:0097159 | 1.05 |
regulatory region DNA binding | GO:0000975 | 3.03 |
regulatory region nucleic acid binding | GO:0001067 | 3.03 |
tumor necrosis factor receptor binding | GO:0005164 | 6.3 |
cytokine activity | GO:0005125 | 4.34 |
binding | GO:0005488 | 0.18 |
protease binding | GO:0002020 | 5.08 |
DNA binding | GO:0003677 | 1.92 |
receptor binding | GO:0005102 | 2.43 |
heterocyclic compound binding | GO:1901363 | 1.06 |
identical protein binding | GO:0042802 | 2.63 |